SCHEMBL21654547

SCHEMBL21654547

Cc1ccc(-c2ccc(-c3ncc(C)cn3)cn2)nc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.67
CCR5 P51681 1/20 0.67
CCR8 P51685 1/20 0.67
HDAC6 Q9UBN7 1/20 0.67
METAP2 P50579 2/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2A6 P11509 1/20 0.47
PTGS2 P35354 2/20 0.41
NOS3 P29474 1/20 0.40
NOS2 P35228 1/20 0.40
GRM5 P41594 2/20 0.40
METAP1 P53582 1/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM1A O60341 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17051526 0.90 CCR1 (0.52) CCR1CCR5CCR8HDAC6METAP2
SCHEMBL12628202 0.88 CCR1 (0.67) CCR1CCR5CCR8HDAC6METAP2
SCHEMBL17051539 0.88 CCR1 (0.60) CCR1CCR5CCR8HDAC6METAP2
SCHEMBL17051557 0.86 CCR1 (0.58) CCR1CCR5CCR8HDAC6METAP2
SCHEMBL20842553 0.85 CCR1 (0.57) CCR1CCR5CCR8HDAC6METAP2
SCHEMBL14804380 0.85 CCR1 (0.76) CCR1CCR5CCR8HDAC6METAP2
SCHEMBL14804374 0.83 CCR1 (0.73) CCR1CCR5CCR8HDAC6METAP2
SCHEMBL17051563 0.82 CYP3A4 (0.47) CCR1CCR5CCR8HDAC6CYP3A4
SCHEMBL17055552 0.82 NPC1 (0.50) CCR1CCR5CCR8HDAC6CYP3A4
SCHEMBL17051506 0.82 CCR1 (0.71) CCR1CCR5CCR8HDAC6METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544365-B2 Nematic liquid crystal composition DIC CORPORATION (JP) 2020-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10544365-B2 Nematic liquid crystal composition DOCK5, CDKL5, NCS1 CCR1 325/4885CCR5 459/4885CCR8 993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.